Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|April 6, 2021
Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset HypophosphatasiaWei-Jian Pan, Rajendra Pradhan, Ryan Pelto, et al.
Frontiers in Neurology|November 22, 2021
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum DisorderPratap Singh, Xiang Gao, Huub Jan Kleijn, et al.
Frontiers in Neurology|November 19, 2021
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia GravisJonathan P R Monteleone, Xiang Gao, Huub Jan Kleijn, et al.
Physical Chemistry Chemical Physics : PCCP|May 20, 2006
Origin of the bathochromically shifted optical spectra of meso-tetrathien-2'- and 3'-ylporphyrins as compared to meso-tetraphenylporphyrinChristian Brückner, Paul C D Foss, James O Sullivan, et al.
Bioanalysis|February 3, 2026
Mitigation of pre-existing immunogenicity in ADA method developmentJihua Chen, Henry Zhao, Chris Gardner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 13, 2024
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasiaKathryn M Dahir, Amy Shannon, Derek Dunn, et al.
The AAPS Journal|August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker AssessmentMitra Azadeh, Jeremy Good, Michele Gunsior, et al.
The Journal of Applied Laboratory Medicine|September 3, 2024
Total Copper and Labile Bound Copper Fraction as a Selective and Sensitive Tool in the Evaluation of Wilson DiseaseJoshua A Bornhorst, Anna C Bitzer, Patrick L Day, et al.
Bioanalysis|December 23, 2025
A systematic approach to improve the initial success rates of bioanalytical assay transfers to contract research organizationsMing Li, Jay Ma, Mark Ma, et al.
Bioanalysis|January 6, 2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)Omar Tounekti, Sophie Shubow, Sarah Wassmer, et al.
Pageof 1